Synthesis of lipids for development of multifunctional lipid-based drug-carriers

被引:6
作者
Zhu, Guodong [1 ]
Alhamhoom, Yahya [1 ]
Cummings, Brian S. [1 ]
Arnold, Robert D. [1 ]
机构
[1] Univ Georgia, Dept Pharmaceut & Biomed Sci, Coll Pharm, Athens, GA 30602 USA
关键词
Liposomes; Phospholipids; Secretory phospholipase A(2); Synthesis; SECRETORY PHOSPHOLIPASE A(2); GROUP-II PHOSPHOLIPASE-A2; TUMOR XENOGRAFT MODEL; PHOTOINITIATED DESTABILIZATION; LIPOSOMES; RELEASE; DELIVERY; CANCER; HYPERTHERMIA; EXPRESSION;
D O I
10.1016/j.bmcl.2011.08.103
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A simple approach to synthesize phospholipids to modulate drug release and track lipid-based particulate drug-carriers is described. We synthesized two ether lipids, 1 1-O-hexadecyl-2-pentadenoyl-sn-glycerol- 3-phosphocholine (C31PC) and 2 1-O-hexadecyl-2-pentadenoyl-sn-glycerol-3-phosphomethanol (C31PM), and examined their ability to alter enzymatically triggered release of 6-carboxyfluorescein from liposomes incubated in TRIS buffer or fetal bovine serum solutions. Further, we demonstrated that odd-chain lipids, for example, C31PC, could be identified in rat plasma without interference of endogenous lipids. This approach can be adapted to synthesize a variety of lipids for use in developing and optimizing multifunctional drug-carriers. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:6370 / 6375
页数:6
相关论文
共 33 条
[1]  
Andresen Thomas L., 2005, Current Drug Delivery, V2, P353, DOI 10.2174/156720105774370203
[2]   Enzymatic release of antitumor ether lipids by specific phospholipase A2 activation of liposome-forming prodrugs [J].
Andresen, TL ;
Davidsen, J ;
Begtrup, M ;
Mouritsen, OG ;
Jorgensen, K .
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (07) :1694-1703
[3]  
BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
[4]   Photoinitiated destabilization of sterically stabilized liposomes [J].
Bondurant, B ;
Mueller, A ;
O'Brien, DF .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2001, 1511 (01) :113-122
[5]  
Cummings BS, 2000, J PHARMACOL EXP THER, V294, P793
[6]   Drug delivery by phospholipase A2 degradable liposomes [J].
Davidsen, J ;
Vermehren, C ;
Frokjaer, S ;
Mouritsen, OG ;
Jorgensen, K .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2001, 214 (1-2) :67-69
[7]   Oncogenic action of phospholipase A2 in prostate cancer [J].
Dong, Qihan ;
Patel, Manish ;
Scott, Kieran F. ;
Graham, Garry G. ;
Russell, Pamela J. ;
Sved, Paul .
CANCER LETTERS, 2006, 240 (01) :9-16
[8]   Pharmacokinetics and In Vivo Drug Release Rates in Liposomal Nanocarrier Development [J].
Drummond, Daryl C. ;
Noble, Charles O. ;
Hayes, Mark E. ;
Park, John W. ;
Kirpotin, Dmitri B. .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2008, 97 (11) :4696-4740
[9]  
Drummond DC, 1999, PHARMACOL REV, V51, P691
[10]  
Graff JR, 2001, CLIN CANCER RES, V7, P3857